Levomilnacipran

Levomilnacipran

SCHEMBL1289763

CCN(CC)C(=O)C1(c2ccccc2)C[C@@H]1CN.Cl

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC6A2SLC6A4

The experimentally established mechanism targets of Levomilnacipran. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
SLC6A2 known ✓ P23975 10/20 1.00
SLC6A4 known ✓ P31645 9/20 0.97
KDM4E B2RXH2 1/20 1.00
MAPK1 P28482 1/20 1.00
SLC6A3 Q01959 4/20 0.97
CYP2D6 P10635 1/20 0.97
HTR2C P28335 1/20 0.97

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Milnacipran SCHEMBL1156056 1.00 SLC6A2 (1.00) SLC6A2KDM4EMAPK1SLC6A4SLC6A3
Levomilnacipran SCHEMBL16163256 1.00 SLC6A2 (1.00) SLC6A2KDM4EMAPK1SLC6A4SLC6A3
1R,2S-Milnacipran SCHEMBL4434769 1.00 SLC6A2 (1.00) SLC6A2KDM4EMAPK1SLC6A4SLC6A3
Levomilnacipran SCHEMBL1148742 1.00 SLC6A2 (1.00) SLC6A2KDM4EMAPK1SLC6A4SLC6A3
1R,2S-Milnacipran SCHEMBL161558 1.00 SLC6A2 (1.00) SLC6A2KDM4EMAPK1SLC6A4SLC6A3
1R,2S-Milnacipran SCHEMBL8099 0.99 SLC6A2 (1.00) SLC6A2KDM4EMAPK1SLC6A4SLC6A3
Levomilnacipran SCHEMBL12027608 0.99 SLC6A2 (1.00) SLC6A2KDM4EMAPK1SLC6A4SLC6A3
1R,2S-Milnacipran SCHEMBL30083111 0.99 SLC6A2 (1.00) SLC6A2KDM4EMAPK1SLC6A4SLC6A3
Milnacipran SCHEMBL114034 0.99 SLC6A2 (1.00) SLC6A2KDM4EMAPK1SLC6A4SLC6A3
Levomilnacipran SCHEMBL1707471 0.99 SLC6A2 (1.00) SLC6A2KDM4EMAPK1SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012046247-A2 PROCESS FOR THE PREPARATION OF (±M1R(S), 2SRR)L-2-(AMINOMETHYL)-N,N-DIETHYL-L-PHENYLCYCLOPROPANE CARBOXAMIDE HYDROCHLORIDE MSN LABORATORIES LIMITED (IN) 2012-04-12 WO disclosed